Bharat Nutraceuticals: Bridging Innovation, Global Markets, and Sustainable Well-Being

Dr. L Kottu, EU Business Expansion & Research Strategy Specialist Head of EU Collaborations The Netherlands

Dr. L Kottu

EU Business Expansion & Research Strategy Specialist Head of EU Collaborations The Netherlands

Healthcare innovation increasingly depends on the ability to connect scientific ideas with the right clinical, research and market ecosystems. Growing engagement between Europe and India is creating signifi­cant opportunities for healthcare innovators on both sides.

India offers a large and diverse healthcare landscape, ex­perienced clinicians, expanding research capabilities and growing openness to advanced medical technologies. How­ever, successful collaboration requires local understand­ing, trusted institutional relationships and an ability to align innovation with clinical relevance, accessibility and affordability.

Bharat Nutra MedTech, a specialized MedTech division of Bharat Nutraceuticals, was established to address this growing need. Rather than functioning merely as a market-entry intermediary, the division seeks to build meaningful connections between international innovators and India’s hospitals, clinicians, research institutions and other healthcare stakeholders, creating appropriate pathways for cross-border collaboration and technology adoption.

From India’s Natural Resources to a Broader Vision for Well-Being

Bharat Nutraceuticals was founded in 2019 with a vision to explore the potential of Indian herbs and natural products and develop solutions that could contribute to healthier lifestyles in India and international markets. From the beginning, however, the founders saw health and well-being through a broader lens encompassing food, agriculture, nutraceuticals, scientific research and, eventually, healthcare technology.

The COVID pandemic marked an important phase in this progression, prompting the company to strengthen its emphasis on research and development. Sustained research efforts led one of the company’s directors to secure patent rights in multiple countries, reinforcing the team’s belief that meaningful and resource-efficient innovation developed in India can gain international relevance.

This experience encouraged the organization to look beyond its original areas of activity. Bharat Nutra MedTech subsequently emerged as a specialized division focused on healthcare technologies, research collaboration, international partnerships and cross-border market engagement.

The progression ref lects the founders’ broader vision of working across the principal pillars of healthy well-being while remaining closely connected to social impact. Their commitment extends to supporting farming communities and contributing to welfare and empowerment initiatives for people from lower socioeconomic backgrounds. As the organization expands into newer areas, accessibility and meaningful societal value continue to influence its direction.

At Bharat Nutraceuticals, nature inspires and innovation drives progress—shaping sustainable solutions across food, nutrition, healthcare and medical technology in pursuit of lasting health and well-being

Dr. L Kottu, EU Business Expansion & Research Strategy Specialist Head of EU Collaborations The Netherlands

Connecting Global Innovation with India’s Healthcare Ecosystem

A major strength of Bharat Nutra MedTech is its growing network of hospitals, clinicians, research institutions, industry stakeholders and international innovators. This ecosystem enables the division to understand a technology not only from a commercial perspective, but also in terms of its clinical relevance, practical applicability and potential contribution to healthcare.

Led by Dr. L. Kottu, PhD, a physician-scientist with international experience in clinical, pre-clinical cardiac and epidemiological research, medical technology and cross-border partnerships - the team assesses whether a technology addresses a genuine healthcare need, offers meaningful clinical value and has potential within the intended market. It also considers the available scientific evidence, patient relevance and practical requirements for implementation.

Where further evaluation or research may be relevant, the organization connects innovators with appropriate hospitals, research institutions, clinicians and independent specialized partners across continents.

Moving Global Partnerships from Vision to Reality

Bharat Nutra MedTech’s role is centered on bridging the gap between healthcare innovators and the stakeholders relevant to their entry into new markets. Recognising the complexities of cross-border expansion, the division seeks to make the process more structured, informed and collaborative.

European technologies may need adaptation in areas such as pricing, clinical workflow, infrastructure, user expectations or regional deployment. The organization works to identify these considerations early by engaging with clinicians, institutions and prospective partners.

Such feedback enables innovators to determine whether a technology is ready for broader engagement or whether localisation, additional evidence, partnership development or a phased approach could offer stronger long-term potential. For selected innovations, the organization promotes pilot projects as a practical bridge to long-term adoption—providing real-world market insights and building confidence among innovators and end users.

Trust remains fundamental to this model. The objective is not to accelerate every opportunity towards immediate commercialization, but to build partnerships where scientific merit, healthcare relevance and practical feasibility are aligned.

Building a Two-Way Innovation Corridor

The long-term ambition extends beyond bringing European technologies into India. It envisions a two-way innovation corridor that also connects relevant Indian products, research capabilities and natural well-being solutions with opportunities across Europe and beyond.

AI-enabled diagnostics, clinical decision-support, medical robotics, remote monitoring, advanced technologies, precision medicine and data-driven healthcare are among the areas the specialized division identifies as offering significant potential for future collaboration.

India’s clinical diversity, research scale and growing technology ecosystem can complement European scientific and engineering strengths, creating opportunities for collaborative evaluation, research partnerships and responsible technology deployment.

At the same time, Bharat Nutraceuticals’ broader foundation in natural products and wellness creates another dimension for international engagement. Guided by the vision of its Co-Founder, Jagadeesh Sreenivas, the organization aims to explore pathways for carefully developed Indian products, including those drawing on natural ingredients and India’s Ayurvedic heritage, to reach suitable global markets especially EU market. This ambition also reflects the growing momentum in EU–India trade and investment relations, creating new possibilities for cross-border innovation and strategic partnerships.

Going forward, Bharat Nutra MedTech intends to deepen its international networks and strengthen its ability to connect innovators with relevant stakeholders across markets. Anchored in Bharat Nutraceuticals’ broader vision of health, innovation, accessibility and social progress, the division seeks to become a trusted bridge for meaningful, long-term cross-border healthcare collaboration.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.